ABT | Abbott Laboratories Stock Overview

(Stock Exchange: NYSE)

Day's Range	115.53 - 116.74
52 Week Range	99.71 - 121.64
Beta	0.76
Implied Volatility	22.08%
IV Rank	40.95%
Day's Volume	3,612,321
Average Volume	4,903,181
Shares Outstanding	1,734,460,000
Market Cap	201,075,947,800
Sector	Healthcare
Industry	Medical - Devices
IPO Date	1980-03-17

Valuation
Profitability
Growth
Health
P/E Ratio	35.24
Forward P/E Ratio	18.80
EPS	3.29
1YR Price Target	123.00
Dividend Yield	1.88%
Dividend Per Share	1.28
Dividend ExDate	2022-10-13
Dividend PayDate	2022-11-15
Employees	114,000
Country	USA
Website	ABT

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

ABT's peers: ABBV, LLY, BMY, JNJ, MDT, ALGN, BSX, DXCM, EW, INMD, MASS, NNOX, PHG, PODD, SENS, SYK, TNDM, ZBH

*Chart delayed

Analyzing fundamentals for ABT we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is poor, Growth is very good and Health is frighteningly weak. For more detailed analysis please see ABT Fundamentals page.

Watching at ABT technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ABT Technicals page.